Renalytix (RENX) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free RENX Stock Alerts GBX 23 -0.50 (-2.13%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 9, 2024 | uk.finance.yahoo.comIs Renalytix the best penny stock to buy today?February 17, 2024 | finance.yahoo.comRNLX Mar 2024 2.500 callFebruary 15, 2024 | finanznachrichten.deRenalytix plc: Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024February 15, 2024 | uk.investing.comRenalytix AI plc (RENX)February 14, 2024 | nz.finance.yahoo.comRenalytix Plc (RNLX) stock price, news, quote & history – Yahoo FinanceFebruary 13, 2024 | morningstar.comRenalytix PLC RENXFebruary 13, 2024 | uk.finance.yahoo.comAfter the Renalytix share price jumps 500% in 3 days, is it time to buy?January 10, 2024 | finanznachrichten.deRenalytix plc: New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney diseaseNovember 15, 2023 | benzinga.comRenalytix Stock (NASDAQ:RNLX) Earnings Dates and Earning CallsSeptember 28, 2023 | markets.businessinsider.comRenalytix Reports Full Year Fiscal 2023 ResultsSeptember 7, 2023 | finance.yahoo.comRenalytix Appoints Senior Executive Howard Doran as Chief Business OfficerJuly 3, 2023 | finance.yahoo.comRenalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsJune 29, 2023 | finance.yahoo.comFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseJune 15, 2023 | finance.yahoo.comKidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific ConferencesMay 31, 2023 | uk.movies.yahoo.comIs the Renalytix share price a bargain or a falling knife?April 20, 2023 | marketwatch.comNew Published Real-World Evidence Shows KidneyIntelX(TM) UtilityApril 19, 2023 | finance.yahoo.comNew Published Real-World Evidence Shows KidneyIntelX™ UtilityApril 12, 2023 | finance.yahoo.comData Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical MeetingMarch 30, 2023 | finance.yahoo.comRenalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial ResultsMarch 21, 2023 | marketwatch.comRenalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelXFebruary 9, 2023 | finance.yahoo.comRenalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFebruary 8, 2023 | finance.yahoo.comRenalytix announces a c.$20.3 million private placementJanuary 26, 2023 | marketwatch.comRenalytix Shares Rise on $10 Mln Grant Award to Advance Chronic Kidney Disease TreatmentJanuary 26, 2023 | finance.yahoo.comRenalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United StatesJanuary 9, 2023 | finance.yahoo.comRenalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systemsDecember 1, 2022 | finance.yahoo.comPrimary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and OutcomesNovember 30, 2022 | finanznachrichten.deRenalytix AI, Inc.: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023November 30, 2022 | msn.comWhat’s going on with the Renalytix share price?October 31, 2022 | finanznachrichten.deRenalytix plc: Renalytix Reports Full Year Fiscal 2022 ResultsOctober 24, 2022 | finance.yahoo.comRenalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31September 20, 2022 | finance.yahoo.comRenalytix Announces Change to Board of DirectorsAugust 17, 2022 | uk.finance.yahoo.comRenalytix Plc (RENX.L)August 8, 2022 | finance.yahoo.comData Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care PhysiciansJune 30, 2022 | fool.co.ukHere’s why the Renalytix share price is tankingJune 30, 2022 | finance.yahoo.comRenalytix Reports Financial Results for Third Quarter of Fiscal Year 2022June 16, 2022 | uk.finance.yahoo.comThe Renalytix share price – where next?June 10, 2022 | finance.yahoo.com1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease PatientsJune 6, 2022 | finance.yahoo.comKidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient CohortJune 3, 2022 | stockhouse.comRenalytix Announces Two Data Presentations on KidneyIntelX(TM) at American Diabetes Association 82nd Scientific Sessions®June 3, 2022 | yahoo.comDan Levy Channeled His FOMO Into Directing His New Tostitos Ad: 'It's Very Real'April 8, 2022 | finance.yahoo.comRenalytix plc successful completion of $30.0 million financing packageMarch 31, 2022 | ca.finance.yahoo.comRenalytix announces a $30.0 million financing packageMarch 10, 2022 | proactiveinvestors.comFragrant Prosperity slumps as reverse takeover falls throughFebruary 24, 2022 | finance.yahoo.comKidneyIntelX™ Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of CareFebruary 22, 2022 | lse.co.ukRenalytix Plc Share ChatJanuary 11, 2022 | finance.yahoo.comPositive Study Results Published for KidneyIntelX™ in Monitoring Patient Response to New Drug TherapyJanuary 5, 2022 | finance.yahoo.comRenalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare ConferenceDecember 9, 2021 | lse.co.ukRenalytix loss widens in first quarter amid higher R&D spendingNovember 9, 2021 | finance.yahoo.comSt. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New YorkOctober 8, 2021 | finance.yahoo.comRenalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21 Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address The CHIPS Act Motherlode (Ad)If you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this. Click here to see my #1 investment for 2024. RENX Media Mentions By Week RENX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENX News Sentiment▼0.000.42▲Average Medical News Sentiment RENX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENX Articles This Week▼00▲RENX Articles Average Week Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cambridge Cognition News Today Induction Healthcare Group News Today Kooth News Today C4X Discovery News Today Arecor Therapeutics News Today Sareum News Today OKYO Pharma News Today Novacyt News Today Hemogenyx Pharmaceuticals News Today Venture Life Group News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
